151 related articles for article (PubMed ID: 32084521)
1. Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver.
Daga M; de Graaf IAM; Argenziano M; Barranco ASM; Loeck M; Al-Adwi Y; Cucci MA; Caldera F; Trotta F; Barrera G; Casini A; Cavalli R; Pizzimenti S
Toxicol In Vitro; 2020 Jun; 65():104800. PubMed ID: 32084521
[TBL] [Abstract][Full Text] [Related]
2. GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses.
Daga M; Ullio C; Argenziano M; Dianzani C; Cavalli R; Trotta F; Ferretti C; Zara GP; Gigliotti CL; Ciamporcero ES; Pettazzoni P; Corti D; Pizzimenti S; Barrera G
Free Radic Biol Med; 2016 Aug; 97():24-37. PubMed ID: 27184956
[TBL] [Abstract][Full Text] [Related]
3. Is the combinational administration of doxorubicin and glutathione a reasonable proposal?
Shen BY; Chen C; Xu YF; Shen JJ; Guo HM; Li HF; Li XN; Kang D; Shao YH; Zhu ZP; Yin XX; Xie L; Wang GJ; Liang Y
Acta Pharmacol Sin; 2019 May; 40(5):699-709. PubMed ID: 30218071
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q
Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermia improves therapeutic efficacy of doxorubicin carried by mesoporous silica nanocontainers in human lung cancer cells.
Lee H; Kim S; Choi BH; Park MT; Lee J; Jeong SY; Choi EK; Lim BU; Kim C; Park HJ
Int J Hyperthermia; 2011; 27(7):698-707. PubMed ID: 21992562
[TBL] [Abstract][Full Text] [Related]
6. Biological Effect Evaluation of Glutathione-Responsive Cyclodextrin-Based Nanosponges: 2D and 3D Studies.
Argenziano M; Foglietta F; Canaparo R; Spagnolo R; Della Pepa C; Caldera F; Trotta F; Serpe L; Cavalli R
Molecules; 2020 Jun; 25(12):. PubMed ID: 32560204
[TBL] [Abstract][Full Text] [Related]
7. Redox-responsive cisplatin nanogels for anticancer drug delivery.
Zhang W; Tung CH
Chem Commun (Camb); 2018 Jul; 54(60):8367-8370. PubMed ID: 29995047
[TBL] [Abstract][Full Text] [Related]
8. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
[TBL] [Abstract][Full Text] [Related]
9. pH/Reduction Dual-Responsive Oxidized Alginate-Doxorubicin (mPEG-OAL-DOX/Cys) Prodrug Nanohydrogels: Effect of Complexation with Cyclodextrins.
Zhou T; Li J; Jia X; Zhao X; Liu P
Langmuir; 2018 Jan; 34(1):416-424. PubMed ID: 29237263
[TBL] [Abstract][Full Text] [Related]
10. Zinc finger-inspired nanohydrogels with glutathione/pH triggered degradation based on coordination substitution for highly efficient delivery of anti-cancer drugs.
Zhang Z; Wan J; Sun L; Li Y; Guo J; Wang C
J Control Release; 2016 Mar; 225():96-108. PubMed ID: 26812007
[TBL] [Abstract][Full Text] [Related]
11. Glutathione responsive cubic gel particles cyclodextrin metal-organic frameworks for intracellular drug delivery.
Xue Q; Ye C; Zhang M; Hu X; Cai T
J Colloid Interface Sci; 2019 Sep; 551():39-46. PubMed ID: 31075632
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin nanosponge for the GSH-mediated delivery of Resveratrol in human cancer cells.
Palminteri M; Dhakar NK; Ferraresi A; Caldera F; Vidoni C; Trotta F; Isidoro C
Nanotheranostics; 2021; 5(2):197-212. PubMed ID: 33564618
[TBL] [Abstract][Full Text] [Related]
13. Fibrin Gels Entrapment of a Poly-Cyclodextrin Nanocarrier as a Doxorubicin Delivery System in an Orthotopic Model of Neuroblastoma: Evaluation of In Vitro Activity and In Vivo Toxicity.
Viale M; Vecchio G; Monticone M; Bertone V; Giglio V; Maric I; Cilli M; Bocchini V; Profumo A; Ponzoni M; Emionite L; Rocco M
Pharm Res; 2019 Jun; 36(8):115. PubMed ID: 31161432
[TBL] [Abstract][Full Text] [Related]
14. Cyclodextrin Polymers as Delivery Systems for Targeted Anti-Cancer Chemotherapy.
Bognanni N; Viale M; Distefano A; Tosto R; Bertola N; Loiacono F; Ponassi M; Spinelli D; Pappalardo G; Vecchio G
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641590
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
Wiradharma N; Tong YW; Yang YY
Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
[TBL] [Abstract][Full Text] [Related]
16. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
[TBL] [Abstract][Full Text] [Related]
17. Facile Synthesis of Fluorescent Hyper-Cross-Linked β-Cyclodextrin-Carbon Quantum Dot Hybrid Nanosponges for Tumor Theranostic Application with Enhanced Antitumor Efficacy.
Pei M; Pai JY; Du P; Liu P
Mol Pharm; 2018 Sep; 15(9):4084-4091. PubMed ID: 30040427
[TBL] [Abstract][Full Text] [Related]
18. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.
Mizusako H; Tagami T; Hattori K; Ozeki T
J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848
[TBL] [Abstract][Full Text] [Related]
19. pH- and GSH-Sensitive Hyaluronic Acid-MP Conjugate Micelles for Intracellular Delivery of Doxorubicin to Colon Cancer Cells and Cancer Stem Cells.
Debele TA; Yu LY; Yang CS; Shen YA; Lo CL
Biomacromolecules; 2018 Sep; 19(9):3725-3737. PubMed ID: 30044910
[TBL] [Abstract][Full Text] [Related]
20. Glutathione Bioresponsive Cyclodextrin Nanosponges.
Trotta F; Caldera F; Dianzani C; Argenziano M; Barrera G; Cavalli R
Chempluschem; 2016 May; 81(5):439-443. PubMed ID: 31968779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]